|   |   | 


































Pharmacology Seminars

Recognizing the 50th anniversary of the discovery of 5-FU by Dr. Charles Heidelberger
at the McArdle Laboratory for Cancer Research, UW-Madison
(Fluorinated pyrimidines, a new class of tumour-inhibitory compounds.
Nature 179:663-6, 1957)

The Cancer Pharmacology group at the UWCCC invites faculty, students and fellows, as well as representatives of local biotechnology companies, to attend a series of research seminars on translational cancer research dealing with anti-cancer target and drug discovery, pre-clinical studies and early clinical evaluation of anti-cancer therapies. Those interested in presenting should contact Michael Hoffmann at fmhoffma@wisc.edu.


Location: UW Hospital and Clinics K4-618
Time: Second Thursday of the Month
8am
Contact: Dr. Michael Hoffmann
fmhoffma@facstaff.wisc.edu
September 13, 2007 Bryce Nelson
VP Research & Development
GenTel BioSciences, Inc. Madison, WI

Clinical Applications of Multiplex Protein Detection in Serum
October 11, 2007 Manish Patankar
Department of Obstetrics and Gynecology
UW-Madison

The role of the mucin MUC16 (CA125) in pathogenesis of ovarian cancer and other gynecologic conditions
November 8, 2007 B .Jack Longley
Department of Dermatology
UW-Madison

MAGE Tumor Antigens Bind Kap-1, Suppress p53, and are Novel Targets for Cancer Therapy
December 13, 2007 Shannon Kenney
Departments of Oncology and Medicine
UW-Madison

Development of New EBV-based Therapies For EBV-positive Malignancies
January 10, 2008 David Vail
Director, Center for Clinical Trials and Research
School of Veterinary Medicine
UW-Madison

Spontaneous tumor models in companion (pet) species: Bridging the gap between drug discover and application
February 14, 2008 Richard Halberg
Department of Oncology
UW-Madison

Monitoring the Response of Colonic Tumors in Mouse Models to Drug Therapy Using Optical and Virtual Colonoscopy
March 13, 2008 Nicholas L. Abbott
Department of Chemical and Biological Engineering, UW-Madison

Biomolecular Analysis using Liquid Crystals
April 10, 2008 Herb Chen
Department of Surgery
UW-Madison

Pharmacologic activation of the Notch1 signaling pathway: a possible therapeutic strategy for neuroendocrine cancers
May 8, 2008 Weiping Tang
Division of Pharmaceutical Sciences,
UW-Madison

Selective Inhibition of Histone Deacetylases in Cells and Tissues


Home | For Patients | Research | Funding | Education and Training | Outreach | About Us |
Clinical Trials | Newsroom | Events | Donations | Directions | Site Map |
Terms and Conditions
Copyright 2007 Board of Regents of the University of Wisconsin System